Skip to content
CICigna

What Is CI Fair Value?

Cigna (CI) fair value estimate using multiple valuation models, updated daily.

As of July 16, 2026, Cigna (CI) has a composite fair value estimate of $574.88 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $297.81, suggesting the stock is undervalued by 93.0%.

Data as of July 16, 2026 (today)

Composite Fair Value

Undervalued4 of 4 models

$574.88

vs. current price of $297.81(+93.0%)

Undervalued$574.88Overvalued
$297.81

How Is CI Fair Value Calculated?

Four independent models estimate what CI is worth. Each uses different inputs and assumptions. The composite blends them by weight.

CI Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$936.95

+214.6%

Undervalued

Inputs used

FCF: 6.9BGrowth: 6.0%Discount: 6%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$203.14

-31.8%

Overvalued

Inputs used

Dividend: $6.24/yrReq. Return: 6%Growth: 3.0%

CI Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$330.35

+10.9%

Fair Value

Inputs used

EPS: $30.41Book Value: $159.52

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$304.05

+2.1%

Fair Value

Inputs used

EPS: $30.41Growth: 6.0%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$936.95Undervalued

Current price $297.81 is 214.6% below this estimate

CheapFair ValueExpensive
6.0%
0.0%30.0%
5.5%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$7.34B$6.95B
Year 2$7.78B$6.98B
Year 3$8.25B$7.01B
Year 4$8.74B$7.05B
Year 5$9.27B$7.08B
Year 6$9.82B$7.11B
Year 7$10.41B$7.14B
Year 8$11.04B$7.17B
Year 9$11.70B$7.20B
Year 10$12.40B$7.23B
Terminal Value$417.96B$243.72B

What Are CI's Key Financial Metrics?

Earnings & Growth

Current Price

$297.81

EPS (TTM)

$23.17

Forward P/E

8.9

Profit Margin

2.3%

Cash & Balance Sheet

Free Cash Flow

6.9B

EBITDA

13.4B

Book Value

$159.52

Total Debt

30.9B

What Do Analysts Say About CI?

Low

$290.00

Average

$340.92

High

$400.00

Upside

+14.5%

Current $297.81Avg Target $340.92Buy24 analysts

CI Fair Value FAQ

What is the fair value of CI?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), CI's estimated fair value is $574.88. The stock is currently trading at $297.81, which makes it undervalued by our analysis.

How is CI's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is CI overvalued or undervalued?

Based on our analysis, CI is undervalued. The current price of $297.81 is 93.0% below our estimated fair value of $574.88.

What do Wall Street analysts say about CI?

24 analysts cover Cigna with a consensus rating of "Buy." The average price target is $340.92, ranging from $290.00 to $400.00. This implies 14.5% upside from the current price.